Overview

Efficacy and Safety of XP12B in Women With Menorrhagia

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to determine whether XP12B is effective and safe in the treatment of women with heavy menstrual bleeding associated with menorrhagia.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Ferring Pharmaceuticals
Treatments:
Tranexamic Acid
Criteria
Inclusion Criteria:

- Women with menorrhagia

- 18-49 years of age

- Regularly occurring menstrual periods

Exclusion Criteria:

- History or presence of clinically significant disease or abnormalities that may
confound the study

- History of bilateral oophorectomy or hysterectomy

- Hormone therapy for birth control